Balyasny Asset Management
STIM icon

Balyasny Asset Management’s Neuronetics STIM Stock Holding History

Balyasny Asset Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,743,768
Closed -$3.98M – 3469
2026
Q1 		$3.98M Buy
2,743,768
+191,364
+7% +$303K 0.01% 1466
2025
Q4 		$3.52M Buy
2,552,404
+730,755
+40% +$1.53M ﹤0.01% 1579
2025
Q3 		$4.97M Buy
1,821,649
+312,550
+21% +$1.11M 0.01% 1376
2025
Q2 		$5.27M Buy
1,509,099
+92,048
+6% +$363K 0.01% 1268
2025
Q1 		$5.21M Sell
1,417,051
-64,720
-4% -$236K 0.01% 1226
2024
Q4 		$2.39M Buy
1,481,771
+337,539
+29% +$351K ﹤0.01% 1613
2024
Q3 		$869K Hold
1,144,232
– – ﹤0.01% 2025
2024
Q2 		$2.06M Sell
1,144,232
-25,273
-2% -$72.9K ﹤0.01% 1523
2024
Q1 		$5.57M Sell
1,169,505
-248,217
-18% -$872K 0.01% 1174
2023
Q4 		$4.11M Buy
1,417,722
+21,239
+2% +$33.5K 0.01% 1188
2023
Q3 		$1.89M Buy
1,396,483
+99,928
+8% +$175K ﹤0.01% 1385
2023
Q2 		$2.79M Buy
1,296,555
+373,217
+40% +$905K 0.01% 1264
2023
Q1 		$2.69M Buy
+923,338
New +$4.66M 0.01% 1337

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management's STIM Position: Q2 2026 in Review

Balyasny Asset Management sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 2,743,768 shares — an estimated $3.98M sold.

Balyasny Asset Management first reported a position in STIM in Q1 2023 and held it in 13 quarters. The position peaked at $5.57M in Q1 2024. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Balyasny Asset Management reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 2,743,768 Neuronetics shares in Q2 2026, an estimated $3.98M.
  • Balyasny Asset Management first reported a position in Neuronetics in Q1 2023 and held it in 13 quarters.
  • Balyasny Asset Management's Neuronetics position peaked at $5.57M in Q1 2024.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.